News About: Pharm. Industry
Business information session scheduled for pharmacy owners in July
Mypharm Korea will hold a business information session during early July in order to help pharmacy owners cope with any financial loss they may encounter, as the National Assembly passing a bill permitting the sale of...
Korean drugmakers eye generic Exforge development
Korean pharmaceutical firms are gearing up to enter the ever-growing combination antihypertensive drugs market dominated by foreign drug companies – Novartis, Daiichi Sankyo and Boehringer Ingelhiem.
The patent of ...
Korea approves 39 Viagra generics
As the main patent for Viagra already expired and t its use patent was nullified by the Korean Intellectual Property Tribunal, more generic versions are expected to rush into pharmacies, according to industry official...
Kolmar Korea to spin off businesses
Kolmar Korea officially decided to separate its business into two parts during a special shareholders meeting on Monday.
Under the split-off plan, Kolmar Korea is to break off companies into an investment consultin...
Drugmakers challenge Viagra with diverse dosage forms
Local drug firms are gearing up to enter the 100 billion won anti-impotence drug market as the main patent of the market leader, Pfizer’s Viagra, expired on May 17.
The release of generics is expected to give wider...
Takeda’s thinner margin policy rekindles debate
As Takeda Korea reduced its wholesaler margin up to 4 percent, the company’s lower margin policy is resurfacing in the domestic wholesaling industry.
An emergency committee of the Korea Pharmaceutical Wholesaler As...
Concerns growing over adverse effects of co-marketing with multinational firms
There are worries that Korean drug firms’ co-marketing strategy with foreign firms could result in decreasing investments in research and development, which is considered a future growth engine for the country’s pharm...
Pacific Pharma faces suspension or delisting for non-compliance
Korea Exchange, the country’s bourse operator, announced on Thursday it may suspend the trading of Pacific Pharma shares from July 1 due to their non-compliance to the Listing Act clauses.
KRX said that from the co...
Pfizer loses Viagra patent suit in Korea
Pfizer Inc. lost patent suit in Korea relating to the world’s bestselling anti-impotence pill Viagra, thus Korean-made generic versions are expected to rush into pharmacies.
The Korea Intellectual Property Tribunal...
Pfizer Korea to appeal Viagra case
Pfizer Korea said today it is considering filing an appeal with the Patent Court against the Korea Intellectual Property Tribunal’s ruling in favor of CJ Pharma and several other companies over the nullification of it...
